Down-Regulation of Inhibitor of Apoptosis Proteins by Deguelin Selectively Induces Apoptosis in Breast Cancer Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Down-Regulation of Inhibitor of Apoptosis Proteins by Deguelin Selectively Induces Apoptosis in Breast Cancer Cells

Published:2006-10-11 Issue:1 Volume:71 Page:101-111
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Peng Xiang-Hong,Karna Prasanthi,O'Regan Ruth M.,Liu XiuJu,Naithani Rajesh,Moriarty Robert M.,Wood William C.,Lee Ho-Young,Yang Lily

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference36 articles.

1. Survivin and apoptosis control

2. Validating survivin as a cancer therapeutic target

3. Survivin Expression Is Regulated by Coexpression of Human Epidermal Growth Factor Receptor 2 and Epidermal Growth Factor Receptor via Phosphatidylinositol 3-Kinase/AKT Signaling Pathway in Breast Cancer Cells

4. Survivin as a Radioresistance Factor in Pancreatic Cancer

5. Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway;Acta Pharmaceutica;2024-03-01

2. Deguelin and Paclitaxel Loaded PEG-PCL Nano-Micelles for Suppressing the Proliferation and Inducing Apoptosis of Breast Cancer Cells;Frontiers in Bioscience-Landmark;2024-02-23

3. Exploring the Potential of Dietary Phytochemicals in Cancer Therapeutics: Modulating Apoptosis and Autophagy;Cancer Drug Discovery and Development;2024

4. Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance;Cancers;2021-08-28

5. Recent Advances in Chemotherapeutic Implications of Deguelin: A Plant-Derived Retinoid;The Natural Products Journal;2021-06-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3